Ipamorelin (5mg)
$42.99
Ipamorelin is a synthetic pentapeptide and selective growth hormone secretagogue receptor (GHSR-1a) agonist. In research settings, Ipamorelin is studied for its receptor selectivity profile, pituitary somatotroph GH secretion dynamics, and pharmacological comparison against other GHS compounds.
BioRhex supplies Ipamorelin as a research compound manufactured in a GMP-compliant US facility, tested to ≥99% purity via HPLC and mass spectrometry, and supplied strictly for controlled laboratory research — not for human or animal use.
- In stock
- COA-verified
- ≥99% purity.
- USA manufactured.
- In stock
- COA-verified
- ≥99% purity.
- USA manufactured.
- COA-verified
- In stock
- ≥99% purity.
- USA manufactured.
What Is Ipamorelin?
Ipamorelin is a synthetic pentapeptide and selective growth hormone secretagogue receptor (GHSR-1a) agonist. In research settings, Ipamorelin is studied for its receptor selectivity profile, pituitary somatotroph GH secretion dynamics, and pharmacological comparison against other GHS compounds.
BioRhex supplies Ipamorelin as a research compound manufactured in a GMP-compliant US facility, tested to ≥99% purity via HPLC and mass spectrometry, and supplied strictly for controlled laboratory research — not for human or animal use.
Compound Overview
Ipamorelin is a pentapeptide GH secretagogue studied for its receptor selectivity and GH release characteristics. Preclinical and in vitro research models examine how Ipamorelin may influence:
• GHSR-1a receptor binding and downstream activation signaling
• Pituitary somatotroph GH secretion pulse modeling
• Receptor selectivity — GH pathway vs. ACTH/cortisol co-stimulation
• Hypothalamic-pituitary axis signaling and feedback dynamics
• GH downstream modulation including IGF-1 axis interactions
All findings referenced are from controlled research environments and do not represent clinical outcomes or therapeutic claims.
History of Ipamorelin
Ipamorelin was developed by Novo Nordisk as part of a research program into selective GHSR agonists. Its design prioritized selectivity — specifically GH stimulation with minimal ACTH or cortisol pathway co-activation observed with earlier GHS compounds such as GHRP-6.
Ipamorelin’s receptor selectivity profile made it a valuable tool for studying clean GH axis pharmacology without confounding endocrine activation in preclinical models.
It remains a commonly referenced compound in GH secretagogue research and pituitary axis pharmacology, studied exclusively within controlled laboratory settings.
Molecular Structure
Aib-His-D-2-Nal-D-Phe-Lys-NH₂
Research Findings
Published and preclinical research on Ipamorelin covers several areas of scientific investigation, including:
GHSR-1a pharmacology: Studies examine Ipamorelin’s binding characteristics and signaling dynamics compared to endogenous ghrelin and other GHS compounds.
GH pulse dynamics research: Research investigates pulsatile GH release patterns associated with Ipamorelin receptor activation in experimental systems.
Selectivity profile studies: Laboratory models evaluate minimal cross-reactivity with ACTH, cortisol, and prolactin pathways in preclinical research.
Hypothalamic feedback modeling: Studies explore downstream interactions between Ipamorelin-induced GH release and hypothalamic regulatory mechanisms.
All findings referenced are from controlled, non-clinical research models and do not imply therapeutic or clinical application.
References
FAQ
What type of research is Ipamorelin used for?
What type of research is Ipamorelin used for?
Ipamorelin is used in laboratory research settings. All supplied compounds are intended strictly for in vitro and preclinical research purposes. Use is limited to controlled scientific environments.
Where is BioRhex’s Ipamorelin manufactured?
Where is BioRhex’s Ipamorelin manufactured?
All BioRhex compounds, including Ipamorelin, are manufactured in a GMP-compliant facility located in the United States.
What testing does BioRhex conduct on Ipamorelin?
What testing does BioRhex conduct on Ipamorelin?
Every batch of Ipamorelin undergoes third-party HPLC purity testing, mass spectrometry identity verification, and sterility testing. A Certificate of Analysis is included with every order, documenting batch-specific purity data at a ≥99% threshold.
Is Ipamorelin approved for human use?
Is Ipamorelin approved for human use?
No. Ipamorelin is not FDA-approved and is not intended for human or animal administration. It is supplied exclusively for laboratory research purposes.
Who should handle this compound?
Who should handle this compound?
Only qualified personnel in controlled laboratory settings following appropriate safety and handling protocols.
Research Use Only
All BioRhex compounds are supplied strictly for laboratory research purposes. Not for human or animal consumption, medical use, or therapeutic application. Ipamorelin is not FDA-approved for any medical purpose. Nothing on this page should be interpreted as health guidance or applied outside controlled research settings.
RELATED PRODUCTS
AOD9604 (5mg)
BPC-157
BPC-157 + TB-500
CJC (no DAC) + Ipamorelin (10mg)
